Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.91 USD | -5.91% | -14.60% | -2.53% |
Mar. 08 | Truist Securities Adjusts Price Target on Compugen to $5 From $4, Maintains Buy Rating | MT |
Mar. 05 | Transcript : Compugen Ltd., Q4 2023 Earnings Call, Mar 05, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.53% | 182M | |
-0.95% | 41.71B | |
+47.70% | 41.56B | |
+4.00% | 39.74B | |
-15.14% | 25.61B | |
+3.39% | 24.26B | |
-23.03% | 18.55B | |
-2.11% | 11.93B | |
+25.35% | 11.93B | |
+7.34% | 10.91B |
- Stock Market
- Equities
- CGEN Stock
- News Compugen Ltd.
- Compugen : Commences Dosing in Phase 1 Trial of Combo Therapy for Advanced Malignancies